Urinary bisphenol concentrations and its association with metabolic disorders in the US and Korean populations

被引:36
作者
Choi, Ji Yoon [1 ]
Lee, Jiyun [1 ,2 ]
Huh, Da-An [3 ]
Moon, Kyong Whan [1 ,2 ]
机构
[1] Korea Univ, Grad Sch, Dept Hlth & Safety Convergence Sci, Anam Ro 145, Seoul 02841, South Korea
[2] Korea Univ, BK21 Four R&E Ctr Learning Hlth Syst, Grad Sch, Anam Ro 145, Seoul 02841, South Korea
[3] Korea Univ, Inst Hlth Sci, Anam Ro 145, Seoul 02841, South Korea
关键词
Bisphenol A; Bisphenol S; Bisphenol F; Metabolic disorder; NHANES; KoNEHS; ENDOCRINE-DISRUPTING CHEMICALS; A EXPOSURE; PHTHALATE METABOLITES; INSULIN-RESISTANCE; GENE-EXPRESSION; OBESITY; CHILDREN; ADULTS; WEIGHT; SUBSTITUTES;
D O I
10.1016/j.envpol.2021.118679
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Bisphenol A (BPA) is a representative endocrine disrupting compound used in a vast array of consumer products, and are being frequently substituted by its analogues, bisphenol S (BPS) and bisphenol F (BPF). We aimed to examine the association between urinary bisphenol levels with obesity and lipid profiles in the general population to comprehensively evaluate its potential of metabolic disturbance. A representative sample of 1046 US adults from the National Health and Nutrition Examination Survey (2013-2016) and 3268 Korean adults from the Korean National Environmental Health Survey (2015-2017) was analyzed. We examined the exposure levels of bisphenols and determined their associations with obesity, high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels, and hypercholesterolemia prevalence through multiple linear, and binary/ordinal logistic regression models. In both populations, high BPA levels (lowest tertile vs. 2nd, 3rd tertiles) showed corresponding associations with lipid profile and obesity. BPA levels were associated with decreased HDL-C levels (Q3: beta = -0.053, p = 0.08 (US); Q2: beta = -0.030, p-0.03), increased TG levels (Q3: beta = 0.121, p = 0.029 (US); Q3: beta = 0.089, p = 0.021, and higher odds for obesity (Q3: OR = 1.58, 95% CI: 1.06, 2.35 (US); Q3: OR = 1.41, 95% CI: 1.11, 1.78). Higher BPS levels were positively associated with obesity status, especially in US men (Q2: OR = 1.84, 95% CI: 1.15, 2.96) and Korean women (Q3: OR = 1.27, 95% CI: 0.99, 1.64). A significant decrease in HDL-C (Q3: beta = -0.088, p = 0.01) and elevated odds for obesity at higher BPF levels (Q3: OR = 1.60, 95% CI: 1.00, 2.56) was observed in US women. The findings of our study indicate that BPA and its analogues, BPS and BPF, are associated with lipid metabolism disorders in addition to obesity in adults. Given the increase in exposure to BPA alternatives, continuous biomonitoring, and further investigation of their health effects through prospective cohort studies are warranted.
引用
收藏
页数:11
相关论文
共 83 条
[1]   Exposure to Endocrine-Disrupting Chemicals during Pregnancy and Weight at 7 Years of Age: A Multi-pollutant Approach [J].
Agay-Shay, Keren ;
Martinez, David ;
Valvi, Damaskini ;
Garcia-Esteban, Raquel ;
Basagana, Xavier ;
Robinson, Oliver ;
Casas, Maribel ;
Sunyer, Jordi ;
Vrijheid, Martine .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2015, 123 (10) :1030-1037
[2]   Bisphenol A: Food Exposure and Impact on Human Health [J].
Almeida, Susana ;
Raposo, Antonio ;
Almeida-Gonzalez, Maira ;
Carrascosa, Conrado .
COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, 2018, 17 (06) :1503-1517
[3]  
Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]
[4]  
[Anonymous], 2000, ASIA PACIFIC PERSPEC
[5]  
[Anonymous], 1996, Biological monitoring of chemical exposure in the workplace: guidelines
[6]  
[Anonymous], 2013, National Health and Nutrition Examination Survey: Analytic Guidelines, 2011-2012
[7]  
[Anonymous], 2000, PRACT GUID ID EV TRE
[8]  
Brites F, 2017, BBA CLIN, V8, P66, DOI 10.1016/j.bbacli.2017.07.002
[9]   Statistical Approaches for Estimating Sex-Specific Effects in Endocrine Disruptors Research [J].
Buckley, Jessie P. ;
Doherty, Brett T. ;
Keil, Alexander P. ;
Engel, Stephanie M. .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2017, 125 (06)
[10]  
Bushnik T, 2010, HEALTH REP, V21